Cargando…

Augmentation of implant surfaces with BMP-2 in a revision setting: effects of local and systemic bisphosphonate

AIMS: We wanted to evaluate the effects of a bone anabolic agent (bone morphogenetic protein 2 (BMP-2)) on an anti-catabolic background (systemic or local zoledronate) on fixation of allografted revision implants. METHODS: An established allografted revision protocol was implemented bilaterally into...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cleemann, Rasmus, Sorensen, Mette, West, Andreas, Soballe, Kjeld, Bechtold, Joan E., Baas, Jorgen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The British Editorial Society of Bone & Joint Surgery 2021
Materias:	Bone Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8414437/ https://www.ncbi.nlm.nih.gov/pubmed/34346256 http://dx.doi.org/10.1302/2046-3758.108.BJR-2020-0280.R1

Ejemplares similares

Periosteal Augmentation of Allograft Bone and its Effect on Implant Fixation - An Experimental Study on 12 Dogs()
por: Barckman, Jeppe, et al.
Publicado: (2013)

The Effect on Implant Fixation of Soaking Tricalcium Phosphate Granules in Bisphosphonate
por: Jakobsen, Thomas, et al.
Publicado: (2012)

Rinsing of allograft bone does not improve implant fixation: A study in 12 dogs
por: Barckman, Jeppe, et al.
Publicado: (2013)

Accelerated bone growth, but impaired implant fixation in allograft bone mixed with nano-hydroxyapatite - an experimental study in 12 canines
por: Petersen, Lau Lind, et al.
Publicado: (2022)

Incorporation of raloxifene-impregnated allograft around orthopedic titanium implants impairs early fixation but improves new bone formation: A 4-week study in 12 dogs
por: Hermansen, Lars L, et al.
Publicado: (2015)

Effect of local TGF-β1 and IGF-1 release on implant fixation: comparison with hydroxyapatite coating: A paired study in dogs
por: Lamberg, Anders, et al.
Publicado: (2009)

Strontium doping of bone graft extender: Effect on fixation of allografted experimental implants
por: Vestermark, Marianne T, et al.
Publicado: (2011)

Augmentation of autologous bone graft by a combination of bone morphogenic protein and bisphosphonate increased both callus volume and strength
por: Bosemark, Per, et al.
Publicado: (2013)

Sheep Hip Arthroplasty Model of Failed Implant Osseointegration
por: Jakobsen, Thomas, et al.
Publicado: (2015)

Parathyroid Hormone Treatment Increases Fixation of Orthopedic Implants with Gap Healing: A Biomechanical and Histomorphometric Canine Study of Porous Coated Titanium Alloy Implants in Cancellous Bone
por: Daugaard, Henrik, et al.
Publicado: (2011)

Anabolic and antiresorptive actions of locally delivered bisphosphonates for bone repair: A review
por: Qayoom, I., et al.
Publicado: (2018)

MON-510 Progression of Atypical Femur Stress Fracture after Discontinuation of Bisphosphonate Therapy
por: Gu, Kristine, et al.
Publicado: (2019)

SAT-534 How Has Bisphosphonate Prescribing Changed in the Past Decade for Primary Fracture?
por: Yang, Betsy, et al.
Publicado: (2019)

OR03-4 Atypical Femur Fracture Incidence Increases with Duration of Bisphosphonate Exposure
por: Lo, Joan, et al.
Publicado: (2019)

Acid Etching and Plasma Sterilization Fail to Improve Osseointegration of Grit Blasted Titanium Implants
por: Saksø, Mikkel, et al.
Publicado: (2012)

Systemic intermittent parathyroid hormone treatment improves osseointegration of press-fit inserted implants in cancellous bone: A canine study
por: Daugaard, Henrik, et al.
Publicado: (2012)

SAT-540 Bisphosphonates and Fracture Incidence in Young Adults
por: Choudhary, Manita, et al.
Publicado: (2019)

SAT-502 Bisphosphonates for Treatment of Calcitriol-Induced Hypercalcemia
por: Mateo, Roselyn Cristelle, et al.
Publicado: (2019)

MON-LB67 Bisphosphonate Related Ocular Inflammation
por: Seetharaman, Kavita
Publicado: (2020)

MON-365 Novel Use of Abaloparatide to Augment Spinal Fusion in Patient Undergoing Cervicothoracic Revision Surgery
por: Parikh, Sahil, et al.
Publicado: (2020)

PSAT188 Keeping An Eye On Bisphosphonates: Drug Induced Uveitis
por: Ataallah, Basma, et al.
Publicado: (2022)

SAT-532 Bisphosphonates Prevent Bone Loss Associated with Denosumab Treatment Discontinuation
por: Zanchetta, Maria Belen, et al.
Publicado: (2019)

MON-335 Bisphosphonate and Denosumab Refractory Hypercalcemia of Malignancy: What Else Is at Play?
por: Patel, Reshma, et al.
Publicado: (2020)

ODP124 Sickle Cell Bone Disease and Response to Intravenous Bisphosphonates in Children
por: Todd Alexander, R, et al.
Publicado: (2022)

OR03-5 Fractures during Bisphosphonate Therapy after Orthotopic Liver Transplantation: Incidence and Predictors
por: Bégin, Marie-Josée, et al.
Publicado: (2019)

ODP080 Bisphosphonate treatment for osteoporosis in children with Gorham-Stout syndrome: a case report
por: Ahn, Moon Bae, et al.
Publicado: (2022)

SAT259 A Rare Case Of Bisphosphonate Refractory Hypercalcemia; Cancer Masquerading As Hidradenitis Suppurativa
por: Robles, Lydia A, et al.
Publicado: (2023)

Zoledronate treatment duration is linked to bisphosphonate‐related osteonecrosis of the jaw prevalence in rice rats with generalized periodontitis
por: Messer, Jonathan G., et al.
Publicado: (2019)

THU427 The Benefits Of Oral Bisphosphonates For Elderly Patients With A History Of Long Term Aromatase Inhibitor Use
por: Dominguez, Lorena D, et al.
Publicado: (2023)

Single Dose of Denosumab Effective for Management of Bisphosphonate-Refractory Hypercalcemia of Malignancy Related to Non-Small Cell Lung Cancer
por: Dinh, Kathryn, et al.
Publicado: (2021)

ODP112 Post-infusion ECG Changes in Patients Receiving Intravenous Bisphosphonates: a Systematic Review and Meta-Analysis
por: Shoung, Alex, et al.
Publicado: (2022)

SAT-LB69 Severe Disabling Musculoskeletal Pain as a Side Effect of Bisphosphonates: A Case Report and Review of Literature
por: Bawal, Dionise Ysabelle Vellon, et al.
Publicado: (2020)

SUN-508 Intravenous Bisphosphonates Induced Renal Injury with Nephrotic Range Proteinuria in a Patient with Severe Hypercalcemia Secondary to Parathyroid Carcinoma
por: Gorantla, Yamuna, et al.
Publicado: (2019)

SAT-533 Men with Hypogonadism and Osteoporosis Benefit from Long-Term Testosterone Therapy (TTh) with Testosterone Undecanoate Injections (TU) Regardless of Co-Medication with Bisphosphonates: 10-Year Data from a Controlled Registry Study in a Urological Setting
por: Haider, Ahmad, et al.
Publicado: (2019)

ODP081 Bisphosphonates: To Give or Not to Give, that is the Question – A case of prolonged hypercalcemia in a patient with severe rhabdomyolysis complicated by bilateral foot drop
por: Musurakis, Clio, et al.
Publicado: (2022)

Topical zoledronic acid decreases micromotion induced bone resorption in a sheep arthroplasty model
por: Jakobsen, Thomas, et al.
Publicado: (2017)

Factors Associated With Inadequate Response to Bisphosphonate Therapy in Patients With Osteoporosis in Real-Life Clinical Practice: a Single-Center Retrospective Analysis of 300 Patients
por: Valadares, Luciana Pinto, et al.
Publicado: (2021)

Intermittent parathyroid hormone increases stability and improves osseointegration of initially unstable implants
por: Staats, Kevin, et al.
Publicado: (2022)

Use of Carboxymethyl Cellulose and Collagen Carrier with Equine Bone Lyophilisate Suggests Late Onset Bone Regenerative Effect in a Humerus Drill Defect – A Pilot Study in Six Sheep
por: Jensen, Jonas, et al.
Publicado: (2010)

A degradation fragment of type X collagen is a real-time marker for bone growth velocity
por: Coghlan, Ryan F., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_esqcjrbc3acli6o6b858dthf7o